Moreno-Bost, A., Szmania, S., Stone, K., Garg, T., Hoerring, A., Szymonifka, J., . . . Van Rhee, F. (2010). Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.
Chicago Style aipamenaMoreno-Bost, Amberly, et al. Epigenetic Modulation of MAGE-A3 Antigen Expression in Multiple Myeloma Following Treatment With the Demethylation Agent 5-azacitidine and the Histone Deacetlyase Inhibitor MGCD0103. 2010.
MLA aipamenaMoreno-Bost, Amberly, et al. Epigenetic Modulation of MAGE-A3 Antigen Expression in Multiple Myeloma Following Treatment With the Demethylation Agent 5-azacitidine and the Histone Deacetlyase Inhibitor MGCD0103. 2010.